Boston Scientific Corporation

General ticker "BSX" information:

  • Sector: Health Care
  • Industry: Health Care Equipment & Supplies
  • Capitalization: $123.3B (TTM average)

Boston Scientific Corporation follows the US Stock Market performance with the rate: 70.2%.

Estimated limits based on current volatility of 3.3%: low 88.90$, high 95.02$

Factors to consider:

  • Earnings expected soon, date: 2025-04-23 bmo
  • Company included in S&P500 list
  • US accounted for 9.9% of revenue in the fiscal year ended 2024-12-31
  • Price in estimated range

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2024-12-31 to 2026-12-31

  • 2024-12-31 to 2025-12-31 estimated range: [77.42$, 109.42$]
  • 2025-12-31 to 2026-12-31 estimated range: [70.43$, 101.96$]

Financial Metrics affecting the BSX estimates:

  • Positive: Non-GAAP EPS, $ of 2.51 > 2.18
  • Negative: Industry operating cash flow per share per price (median), % of -3.89 <= 2.91
  • Negative: Industry earnings per price (median), % of -5.86 <= 0
  • Positive: 8.42 < Operating profit margin, % of 15.54

Similar symbols

Short-term BSX quotes

2025-03-032025-03-042025-03-052025-03-062025-03-072025-03-102025-03-112025-03-122025-03-132025-03-142025-03-172025-03-182025-03-192025-03-202025-03-212025-03-242025-03-252025-03-262025-03-272025-03-282025-03-312025-04-012025-04-022025-04-032025-04-042025-04-072025-04-082025-04-092025-04-102025-04-11859095100105
Price $

Long-term BSX plot with estimates

5060708090100110Jul 2023Jan 2024Jul 2024Jan 2025Jul 2025Jan 2026Jul 2026Jan 202700.20.40.6
BSXS&P500Health CareNon-GAAP EPS EstimateNon-GAAP EPS ActualPrice $Non-GAAP EPS $

Financial data

YTD 2022-12-31 2023-12-31 2024-12-31
Operating Revenue $12,660.00MM $14,240.00MM $16,747.00MM
Operating Expenses $11,011.00MM $11,897.00MM $14,144.00MM
Operating Income $1,649.00MM $2,343.00MM $2,603.00MM
Non-Operating Income $-508.00MM $-358.00MM $-321.00MM
Interest Expense $470.00MM $265.00MM $305.00MM
R&D Expense $1,323.00MM $1,414.00MM $1,615.00MM
Income(Loss) $1,141.00MM $1,985.00MM $2,282.00MM
Taxes $443.00MM $393.00MM $436.00MM
Profit(Loss)* $698.00MM $1,593.00MM $1,853.00MM
Stockholders Equity $17,574.00MM $19,282.00MM $21,770.00MM
Inventory $1,867.00MM $2,484.00MM $2,810.00MM
Assets $32,470.00MM $34,887.00MM $39,395.00MM
Operating Cash Flow $1,526.00MM $2,503.00MM $3,435.00MM
Capital expenditure $612.00MM $800.00MM $790.00MM
Investing Cash Flow $-2,011.00MM $-2,574.00MM $-5,687.00MM
Financing Cash Flow $-548.00MM $5.00MM $1,814.00MM
Earnings Per Share** $0.49 $1.10 $1.26

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.